Arvelle Therapeutics

Description: Arvelle Therapeutics develops innovative biopharmaceutical solutions for CNS disorders.

Country: Switzerland

Based in: Basel

Founded: 2019

Funding Stage: Series A/B

Tags: ['Biotechnology', 'innovation']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.